Market Cap 450.69M
Revenue (ttm) 0.00
Net Income (ttm) -99.35M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 320,076
Avg Vol 628,572
Day's Range N/A - N/A
Shares Out 94.88M
Stochastic %K 35%
Beta 0.09
Analysts Strong Sell
Price Target $16.00

Company Profile

Zura Bio Limited, a clinical-stage biotechnology company, develops medicines for autoimmune and inflammatory disorders in the United States. The company develops Tibulizumab, a humanized IgG4 single-chain variable fragment bispecific antibody engineered to bind and neutralize both IL-17A and BAFF within a single therapeutic molecule, which is in Phase 2 clinical trial development. It also develops Torudokimab (ZB-880), a fully human immunoglobulin G4 monoclonal antibody targeting interleukin-33...

Industry: Biotechnology
Sector: Healthcare
Phone: 702 825 9872
Website: zurabio.com
Address:
1489 W. Warm Springs Road, Suite 110, Henderson, United States
focafoca99
focafoca99 May. 7 at 12:14 PM
$ZURA says it released its first‑quarter 2026 financial results via a press release.
0 · Reply
SuperGreenToday
SuperGreenToday May. 4 at 3:36 PM
$ZURA Share Price: $5.47 Contract Selected: Dec 18, 2026 $5 Calls Buy Zone: $0.38 – $0.47 Target Zone: $0.68 – $0.83 Potential Upside: 69% ROI Time to Expiration: 227 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
Breck100
Breck100 Apr. 6 at 3:58 PM
$ZURA Piper Sandler Reaffirms Their Buy Rating on Zura Bio (ZURA) Apr 01, 2026, 07:37 AM Piper Sandler Reaffirms Their Buy Rating on Zura Bio (ZURA) Piper Sandler analyst Yasmeen Rahimi maintained a Buy rating on Zura Bio today and set a price target of $26.00.
0 · Reply
Breck100
Breck100 Mar. 18 at 7:35 PM
$ZURA 3/17/26 Boothbay Fund Management LLC acquired a new position in shares of Zura Bio Limited (NASDAQ:ZURA - Free Report) during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 824,078 shares of the company's stock, valued at approximately $3,568,000. Boothbay Fund Management LLC owned approximately 1.27% of Zura Bio as of its most recent filing with the Securities and Exchange Commission.
0 · Reply
focafoca99
focafoca99 Mar. 5 at 4:31 PM
$ZURA Warrant-related disclosures this morning
0 · Reply
DARKP00L
DARKP00L Mar. 5 at 11:47 AM
$ZURA 06:39 on Mar. 05 2026 Zura Bio Says Design Of Its Ongoing Phase 2 TibuSURE Clinical Trial Evaluating Tibulizumab In SSc Accepted For Presentation At Systemic Sclerosis World Congress #tradeideas
0 · Reply
DARKP00L
DARKP00L Mar. 5 at 11:40 AM
$ZURA 06:39 on Mar. 05 2026 Zura Bio Says Design Of Its Ongoing Phase 2 TibuSURE Clinical Trial Evaluating Tibulizumab In SSc Accepted For Presentation At Systemic Sclerosis World Congress #tradeideas
0 · Reply
StockConsultant
StockConsultant Mar. 3 at 2:22 PM
$ZURA Bio stock, nice trend, watch for a top of range breakout at https://stockconsultant.com/?ZURA
0 · Reply
Emma_Brownnn
Emma_Brownnn Mar. 2 at 4:02 PM
$ZURA 4hr - 7.85 - 10$ can be long targets if momentum continues, mostly 7.85$ & likely rejection down to the blue arrow, if the light blue Trend Line fails to hold then watch for the Lower Trend to be tested @ the blue arrow towards 3.50$ if that 4.75$ area cannot hold after the Trend
0 · Reply
trading_insight
trading_insight Mar. 2 at 4:01 PM
$ZURA - Higher Low Attempt Structure: Forming higher lows off 6.00; holding 6.50 area. RSI: 50 (balanced). MACD: Curling positive. Key Levels Resistance: 6.80 → 7.10 Support: 6.30 → 6.00 Break Trigger: 7.10 Alpha: Constructive above 6.30. 7.10 clears supply for momentum push.
0 · Reply
Latest News on ZURA
Zura Bio names Muzammil Mustufa chief business officer

2026-05-13T12:19:46.000Z - 9 hours ago

Zura Bio names Muzammil Mustufa chief business officer


Zura Bio reports Q1 EPS (22c) vs (19c) last year

2026-05-07T14:42:59.000Z - 6 days ago

Zura Bio reports Q1 EPS (22c) vs (19c) last year


Zura Bio management to meet virtually with Clear Street

2026-04-16T16:15:53.000Z - 27 days ago

Zura Bio management to meet virtually with Clear Street


Zura Bio management to meet with Piper Sandler

2026-03-23T20:25:55.000Z - 7 weeks ago

Zura Bio management to meet with Piper Sandler


Zura Bio price target lowered to $15 from $16 at Oppenheimer

2026-03-20T11:41:41.000Z - 7 weeks ago

Zura Bio price target lowered to $15 from $16 at Oppenheimer


Zura Bio reports FY25 EPS ($1.06) vs (60c) last year

2026-03-19T20:16:13.000Z - 7 weeks ago

Zura Bio reports FY25 EPS ($1.06) vs (60c) last year


Zura Bio Transcript: Leerink Global Healthcare Conference 2026

Mar 10, 2026, 2:20 PM EDT - 2 months ago

Zura Bio Transcript: Leerink Global Healthcare Conference 2026


Zura Bio to Participate in Upcoming Investor Conferences

Mar 2, 2026, 6:30 AM EST - 2 months ago

Zura Bio to Participate in Upcoming Investor Conferences


Zura Bio 18.2M share Spot Secondary priced at $6.25

2026-02-25T12:39:16.000Z - 2 months ago

Zura Bio 18.2M share Spot Secondary priced at $6.25


Zura Bio announces common stock offering, amount not stated

2026-02-24T22:02:41.000Z - 2 months ago

Zura Bio announces common stock offering, amount not stated


Zura Bio spot secondary offering; price range $6.00-$6.25

2026-02-24T22:02:21.000Z - 2 months ago

Zura Bio spot secondary offering; price range $6.00-$6.25


Zura Bio management to meet with Piper Sandler

2026-02-19T13:44:25.000Z - 2 months ago

Zura Bio management to meet with Piper Sandler


Wedbush bullish on Zura Bio, initiates with an Outperform

2026-02-09T12:45:59.000Z - 3 months ago

Wedbush bullish on Zura Bio, initiates with an Outperform


Zura Bio initiated with an Outperform at Wedbush

2026-02-09T11:36:09.000Z - 3 months ago

Zura Bio initiated with an Outperform at Wedbush


Zura Bio CEO Robert Lisicki resigns, Sandeep Kulkarni succeeds

2026-01-21T13:55:23.000Z - 4 months ago

Zura Bio CEO Robert Lisicki resigns, Sandeep Kulkarni succeeds


Zura Bio provides business updates, 2026 outlook

2026-01-12T11:40:55.000Z - 4 months ago

Zura Bio provides business updates, 2026 outlook


Zura Bio Reports Business Updates and Outlook for 2026

Jan 12, 2026, 6:30 AM EST - 4 months ago

Zura Bio Reports Business Updates and Outlook for 2026


Zura Bio reports Q3 EPS (21c), consensus (18c)

2025-11-13T11:40:53.000Z - 6 months ago

Zura Bio reports Q3 EPS (21c), consensus (18c)


Zura Bio initiated with a Buy at Clear Street

2025-11-12T22:25:31.000Z - 6 months ago

Zura Bio initiated with a Buy at Clear Street


Zura Bio Transcript: Cantor Global Healthcare Conference 2025

Sep 4, 2025, 2:45 PM EDT - 8 months ago

Zura Bio Transcript: Cantor Global Healthcare Conference 2025


Zura Bio price target lowered to $2 from $3 at H.C. Wainwright

2025-08-19T10:15:21.000Z - 9 months ago

Zura Bio price target lowered to $2 from $3 at H.C. Wainwright


Zura Bio price target lowered to $16 from $17 at Oppenheimer

2025-08-15T11:45:28.000Z - 9 months ago

Zura Bio price target lowered to $16 from $17 at Oppenheimer


Zura Bio appoints Eric Hyllengren as CFO

2025-07-01T10:36:54.000Z - 11 months ago

Zura Bio appoints Eric Hyllengren as CFO


Zura Bio Announces Chief Financial Officer Transition

Jul 1, 2025, 6:30 AM EDT - 11 months ago

Zura Bio Announces Chief Financial Officer Transition


Zura Bio Announces Participation in June Investor Conferences

May 29, 2024, 6:00 AM EDT - 2 years ago

Zura Bio Announces Participation in June Investor Conferences


Zura Bio Announces Robert Lisicki as CEO and Director

Apr 8, 2024, 6:00 AM EDT - 2 years ago

Zura Bio Announces Robert Lisicki as CEO and Director


Zura Bio Announces Participation at March Conferences

Mar 4, 2024, 6:00 AM EST - 2 years ago

Zura Bio Announces Participation at March Conferences


focafoca99
focafoca99 May. 7 at 12:14 PM
$ZURA says it released its first‑quarter 2026 financial results via a press release.
0 · Reply
SuperGreenToday
SuperGreenToday May. 4 at 3:36 PM
$ZURA Share Price: $5.47 Contract Selected: Dec 18, 2026 $5 Calls Buy Zone: $0.38 – $0.47 Target Zone: $0.68 – $0.83 Potential Upside: 69% ROI Time to Expiration: 227 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
Breck100
Breck100 Apr. 6 at 3:58 PM
$ZURA Piper Sandler Reaffirms Their Buy Rating on Zura Bio (ZURA) Apr 01, 2026, 07:37 AM Piper Sandler Reaffirms Their Buy Rating on Zura Bio (ZURA) Piper Sandler analyst Yasmeen Rahimi maintained a Buy rating on Zura Bio today and set a price target of $26.00.
0 · Reply
Breck100
Breck100 Mar. 18 at 7:35 PM
$ZURA 3/17/26 Boothbay Fund Management LLC acquired a new position in shares of Zura Bio Limited (NASDAQ:ZURA - Free Report) during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 824,078 shares of the company's stock, valued at approximately $3,568,000. Boothbay Fund Management LLC owned approximately 1.27% of Zura Bio as of its most recent filing with the Securities and Exchange Commission.
0 · Reply
focafoca99
focafoca99 Mar. 5 at 4:31 PM
$ZURA Warrant-related disclosures this morning
0 · Reply
DARKP00L
DARKP00L Mar. 5 at 11:47 AM
$ZURA 06:39 on Mar. 05 2026 Zura Bio Says Design Of Its Ongoing Phase 2 TibuSURE Clinical Trial Evaluating Tibulizumab In SSc Accepted For Presentation At Systemic Sclerosis World Congress #tradeideas
0 · Reply
DARKP00L
DARKP00L Mar. 5 at 11:40 AM
$ZURA 06:39 on Mar. 05 2026 Zura Bio Says Design Of Its Ongoing Phase 2 TibuSURE Clinical Trial Evaluating Tibulizumab In SSc Accepted For Presentation At Systemic Sclerosis World Congress #tradeideas
0 · Reply
StockConsultant
StockConsultant Mar. 3 at 2:22 PM
$ZURA Bio stock, nice trend, watch for a top of range breakout at https://stockconsultant.com/?ZURA
0 · Reply
Emma_Brownnn
Emma_Brownnn Mar. 2 at 4:02 PM
$ZURA 4hr - 7.85 - 10$ can be long targets if momentum continues, mostly 7.85$ & likely rejection down to the blue arrow, if the light blue Trend Line fails to hold then watch for the Lower Trend to be tested @ the blue arrow towards 3.50$ if that 4.75$ area cannot hold after the Trend
0 · Reply
trading_insight
trading_insight Mar. 2 at 4:01 PM
$ZURA - Higher Low Attempt Structure: Forming higher lows off 6.00; holding 6.50 area. RSI: 50 (balanced). MACD: Curling positive. Key Levels Resistance: 6.80 → 7.10 Support: 6.30 → 6.00 Break Trigger: 7.10 Alpha: Constructive above 6.30. 7.10 clears supply for momentum push.
0 · Reply
trading_insight
trading_insight Mar. 2 at 3:06 PM
$ZURA From a geopolitical lens, small-cap biotech is relatively insulated from oil shocks and Middle East escalation compared to cyclicals, though in a broad risk-off event liquidity can still pressure secondaries; Alpha scenario: post-offering stabilization and risk rotation into defensives drive a push back toward supply. Beta scenario: escalation-driven equity weakness pulls price back toward the lower demand band despite improved cash runway.
0 · Reply
trading_insight
trading_insight Mar. 2 at 3:06 PM
$ZURA is trading near $6.60 after pricing and closing its $134.6M–$144M public offering at $6.25, which explains the recent supply pressure and rejection near the $7.20 supply zone, while strong demand remains layered around $6.20–$6.35; technically, holding above the offering price is constructive and suggests absorption, with upside toward $7.00–$7.20 if buyers regain control, but a break below $6.20 risks a fade toward $5.90. Fundamentally, the capital raise materially strengthens the balance sheet and reduces near-term financing overhang, which is positive longer term despite dilution.
0 · Reply
AAUS1
AAUS1 Mar. 1 at 2:04 PM
$ZURA scratching my head , really lost
0 · Reply
focafoca99
focafoca99 Feb. 27 at 1:35 PM
$ZURA offering done. What’s next — rally or pullback?
0 · Reply
briefingcom
briefingcom Feb. 25 at 12:55 PM
$ZURA: Zura Bio Limited (-4.3%) announces proposed public offering of Class A Ordinary Shares
1 · Reply
JeffreyCress
JeffreyCress Feb. 24 at 9:06 PM
$ZURA offering…
1 · Reply
Quantumup
Quantumup Feb. 24 at 2:55 PM
TD Cowen reiterated $AVTX at a Buy rating and said, Risk/Reward Skewed To Significant Upside For AVTX-009 Phase Il In Large HS Oppy $ABBV $MLTX $ZURA Here's what else TD Cowen had to say in its note to investors: https://x.com/Quantumup1/status/2026309287077658777?s=20
0 · Reply
StockConsultant
StockConsultant Feb. 24 at 2:29 PM
$ZURA Zura Bio stock, watch for a bull flag breakout at https://stockconsultant.com/?ZURA
1 · Reply